Kenvue Inc.

NYSE KVUE

Kenvue Inc. Price to Book Ratio (P/B) on January 14, 2025: 3.78

Kenvue Inc. Price to Book Ratio (P/B) is 3.78 on January 14, 2025, a 24.07% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Kenvue Inc. 52-week high Price to Book Ratio (P/B) is 4.36 on December 02, 2024, which is 15.36% above the current Price to Book Ratio (P/B).
  • Kenvue Inc. 52-week low Price to Book Ratio (P/B) is 2.70 on March 01, 2024, which is -28.55% below the current Price to Book Ratio (P/B).
  • Kenvue Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 3.55.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
NYSE: KVUE

Kenvue Inc.

CEO Mr. Thibaut Mongon
IPO Date May 4, 2023
Location United States
Headquarters 199 Grandview Road
Employees 22,000
Sector Consumer Staples
Industries
Consumer Packaged Goods Cosmetics Personal Care
Description

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

StockViz Staff

January 15, 2025

Any question? Send us an email